Pharmacological correction endogenous intoxication caused by endometritis in cows

Technical Summary: Pharmacological Correction of Endogenous Intoxication Caused by Endometritis in Cows

Problem Statement
Endometritis is a prevalent inflammatory disease affecting the uterine epithelium in dairy cows, typically diagnosed 21 days or more postpartum. It poses a significant challenge to the global dairy industry by impairing reproductive function, increasing calving-to-conception intervals, reducing conception rates, and causing substantial economic losses through decreased milk production and increased culling. The condition is characterized by endometrial damage, vascular congestion, leukocyte infiltration, and, critically, endogenous intoxication. This intoxication involves the accumulation of medium-weight molecules (MWM) and metabolic disturbances, including altered protein fractions and liver dysfunction. While antibiotic resistance is rising, current therapeutic approaches often lack comprehensive strategies to address both the infection and the resulting systemic metabolic toxicity.

Methodology
The study evaluated the efficacy of a novel complex drug formulation designed to treat endogenous intoxication associated with acute catarrhal-purulent postpartum endometritis.

• Drug Composition: The investigational drug consisted of 4% low-molecular-weight polyvinylpyrrolidone (PVP, MW 8000 ± 2000), 20% dextrose, 10% sodium chloride, and distilled water. It was administered intravenously.
• Experimental Design: A clinical trial was conducted on 20 Black-and-White cows divided into two groups: Group I (10 healthy controls) and Group II (10 cows with acute endometritis).
• Treatment Protocol: Group II animals received the PVP-based solution intravenously at 2 ml/kg daily for 4 days. Prior to administration, streptomycin sulfate (4 mg/kg) was added to the solution based on preliminary antibiotic sensitivity testing. Additionally, pituitrin (5–6 U per 100 kg) was administered subcutaneously twice daily until clinical recovery.
• Ethical Framework: The study adhered to Directive 2010/63/EU and local ethics committee protocols (No. 355-p), ensuring the principles of Replacement, Reduction, and Refinement (3Rs). Procedures were classified as "mild," with analgesia provided prior to manipulation.
• Data Collection: Blood samples were collected from the jugular vein on days 5, 15, and 30 post-treatment initiation. Parameters analyzed included:
  • Hematology: Erythrocytes, hemoglobin, leukocytes, and differential counts.
  • Biochemistry: Total protein, albumin, globulin fractions (α, β, γ), AST, ALT, AP, LDH, urea, cholesterol, and glucose.
  • Endogenous Intoxication Markers: Concentrations of MWM at wavelengths 254 nm and 280 nm, and the Mass Distribution Index (MI = MWM 280/MWM 254).

Key Results
The study demonstrated that the combined therapy effectively reversed hematological and biochemical abnormalities associated with endometritis within 30 days.

• Hematological Recovery: Treated cows exhibited a normalization of blood parameters. Hemoglobin levels increased from 80.7 ± 0.51 g/L (pre-treatment) to 106.2 ± 0.49 g/L (Day 30). Erythrocyte counts decreased from a pathological 10.37 × 10¹²/L to 6.57 × 10¹²/L, and leukocyte counts normalized from 10.89 × 10⁹/L to 6.82 × 10⁹/L. The leukogram shifted from a pathological left shift (neutrophilia, lymphopenia) to physiological norms by Day 15.
• Biochemical Normalization:
  • Intoxication Markers: MWM 254 levels decreased from 0.298 units to 0.185 units, and MWM 280 levels decreased from 0.195 units to 0.149 units by Day 30. The Mass Distribution Index (MI) improved from 0.65 (indicating high catabolic activity) to 0.81, approaching the control value of 0.83.
  • Protein Metabolism: Total protein, albumin, and β-globulins, which were significantly depressed in sick animals, returned to control levels. Conversely, elevated α- and γ-globulins normalized.
  • Enzyme Activity: Elevated liver enzymes (AST, ALT, AP, LDH) indicative of hepatic stress returned to physiological ranges.
  • Metabolites: Glucose levels, which dropped to 2.67 mmol/L, recovered to 4.11 mmol/L.
• Clinical Outcome: Clinical signs, including fever and purulent discharge, resolved rapidly. Appetite returned by Day 3, and vaginal discharge ceased by Day 5. The therapeutic efficacy for acute catarrhal endometritis was reported as 100% over the 4-day treatment course.

Significance and Claims
The authors claim that the developed complex drug demonstrates high therapeutic efficacy by addressing both the infectious agent and the systemic consequences of the disease.

• Synergistic Mechanism: The study posits that the combination of PVP (acting as a detoxifying agent and carrier), glucose, sodium chloride, and streptomycin sulfate creates a synergistic effect. PVP facilitates the binding and removal of toxins, while the antibiotic component targets the pathogenic microflora (identified as E. coli, Staph. aureus, and Strept. pyogenes in related literature).
• Correction of Intoxication: A primary contribution of the work is the documented reduction of endogenous intoxication via the lowering of MWM levels and the restoration of the MI index, suggesting a reversal of the catabolic and toxic state induced by the uterine infection.
• Clinical Recommendation: Based on the complete normalization of hematological and biochemical parameters within 30 days and the stimulation of tissue regeneration, the authors recommend this drug for widespread use in veterinary practice to treat postpartum endometritis in cows.

The paper concludes that this approach offers a viable solution to the economic and reproductive challenges posed by endometritis, particularly in the context of increasing antibiotic resistance, by providing a regimen that rapidly restores physiological homeostasis.